Jianchun Chen - Publications

Correction: Reduced T-cell stemness underlies Th17 expansion and graft dysfunction in kidney transplant recipients.

Journal: Frontiers in genetics

Published: July 02, 2025

Reduced T-Cell stemness underlies Th17 expansion and graft dysfunction in kidney transplant recipients.

Journal: Frontiers in genetics

Published: March 07, 2025

Clonal hematopoiesis of indeterminate potential contributes to accelerated chronic kidney disease progression.

Journal: medRxiv : the preprint server for health sciences

Published: July 01, 2024

MKI67 with arterial hypertension predict a poor survival for prostate cancer patients, a real-life investigation.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 16, 2024

CircTENM3 inhibites tumor progression via the miR-558/RUNX3 axis in prostate cancer.

Journal: Journal of translational medicine

Published: August 09, 2023

LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells.

Journal: PeerJ

Published: August 18, 2022

Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma.

Journal: Aging

Published: April 05, 2022

Castration aggravates insulin resistance, reduces immune function and improves quality of life of prostate cancer patients.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: June 12, 2020

A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.

Journal: International journal of nanomedicine

Published: September 07, 2019

AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: January 19, 2018